dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Mechanism of action for GIP,
Description
Recent studies suggest that these healthy fats may also have a role in GLP-1 activation
Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications
Non-HDL cholesterol and apolipoprotein B may also show modest improvements, which better reflect atherogenic lipoprotein burden
Additionally, it affects a broader population, including non-diabetic individuals using these medications for weight loss
